Cell invasion and migration were inhibited in GBM cells (U87MG and SHG44) treated with ATRA, due to the suppression of matrix metalloproteinase-2 (MMP2) and MMP-9 (Figure 2) [22]. The gene discussed is MMP2; the disease is glioblastoma.